The nation of Zimbabwe has turned down a substantial US health deal worth $367m (272 million pounds) spanning five years over Washington's insistence on confidential biological samples.
This move was revealed after a official document dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
An official spokesman later stated that the United States was demanding access to genetic material for scientific study and commercial purposes while was not willing to share the resulting advantages from any future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for continued talks to reach a deal agreeable to both sides so the country's vital HIV programme can continue.
Broader Implications
This development comes after a comparable case in Kenya, where a court blocked a similar deal with the US following concerns were raised about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump argued its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance openness and responsibility.
Based on statements, Sixteen nations in Africa have to date signed these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to surrender its biological resources and data for a long time, with no corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Put simply, our nation would supply the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our population if a future disease outbreak arise."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the global health body and its push of one-on-one deals were disrupting systems previously set up through the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This framework is intended to guarantee that when a country provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome continued discussions with our US partners on how future co-operation could be structured in a way that respects the independence and dignity of both nations."
Medical Community Response
Medical experts stated it acknowledged the official position, but suggested that talks should continue considering a large portion of the country's HIV programmes depended on foreign aid.
"Where specific concerns arise, including those involving information security or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," it said.
This impasse emphasises the complex challenges between receiving vital international aid and protecting national sovereignty in an ever more interconnected world.